Biotech news
Refine search
Asia
Indonesian lawmakers have announced that hospitals and health clinics are being investigated by authorities after police exposed a group selling fake vaccines aimed at children for more than a decade. 29 June 2016
Americas
The US Supreme Court announced yesterday that it has agreed to hear a patent infringement case between Promega and Life Technologies centring on DNA testing kits used to analyse genetic differences between people. 28 June 2016
Americas
The US Supreme Court has today made its decision to deny a review of the patent dispute between Sequenom and Ariosa Diagnostics over a patent covering pre-natal testing. 27 June 2016
Americas
UK-based diagnostics company Oxford Immunotec has announced that it will acquire Imugen, a US clinical laboratory, for $22.2 million in cash. 27 June 2016
Pharma
The European Patent Office has said that it expects a solution will be found to allow the implementation of the unitary patent despite the referendum result. 24 June 2016
Pharma
The practicalities of litigating disputes were discussed yesterday in the session “Collaboration agreements – What are the best jurisdictions to resolve disputes” at the Life Sciences Law Forum 2016 in London. 24 June 2016
Americas
The US Supreme Court is set to consider today whether to take on a long running patent dispute between Sequenom and Ariosa Diagnostics centring on pre-natal testing. 23 June 2016
Pharma
While pharmaceutical companies are more likely to seek patent protection for their inventions, trade secrets can be useful too, particularly following two recent legislative developments, say Andy Sanderson and Ling Zhuang of Potter Clarkson. 23 June 2016
Americas
A US advisory panel has reportedly approved the use of the CRISPR/Cas9 gene-editing technology on humans for the first time, as part of a study designed to target three types of cancer. 22 June 2016
Americas
The US Supreme Court has invited the solicitor general to file briefs in the Amgen v Sandoz biosimilars case in order to obtain the Obama administration’s view on the dispute between the two companies. 22 June 2016


